Egyptian healthtech startup Reme-D has raised $1.45 million in a Pre-Series A funding round led by Anara Impact Capital to expand its manufacturing capacity and diagnostic product portfolio.
Amount Raised
$1.45 Million
Round Type
Pre-Series A
CairoManufacturingBiotechnologyHealth CareHealth DiagnosticsInvestors
Description
Reme-D, an Egyptian healthtech company developing and manufacturing molecular diagnostic solutions, has closed a $1.45 million Pre-Series A funding round led by Anara Impact Capital. The funding will help Reme-D expand its manufacturing capacity, regional reach, and product portfolio. The company plans to add tests for new disease areas, including genetic diseases and cancer-related tests. Founded in 2023, Reme-D focuses on making advanced diagnostics more accessible across Africa and other underserved markets.
Quick answer
Reme-D raised $1.45 Million in a Pre-Series A round, dated July 20, 2026. Investors: Global Innovation Fund, Africa Health Ventures and Anara Impact Capital. Reme-D is based in Cairo, Cairo, Egypt.
- How much did Reme-D raise?
- Reme-D raised $1.45 Million in a Pre-Series A round on July 20, 2026.
- Who invested in Reme-D?
- Global Innovation Fund, Africa Health Ventures and Anara Impact Capital are named as investors in this round.
- What does Reme-D do?
- Reme-D is an Egyptian healthtech startup focused on developing and manufacturing molecular diagnostic tests for diseases such as tuberculosis, HIV, hepatitis, and HPV.
- Where is Reme-D based and how big is it?
- Reme-D is based in Cairo, Cairo, Egypt.
Source: Fundz verified event record.
Who else raised in Health Diagnostics and Manufacturing around the same time
Companies in the same sectors as Reme-D that raised within 45 days of this round, from Fundz verified event records.
- Cornerstone Robotics raised $700M (Corporate Round) on September 2, 2026.
- iPremom raised $17M (Seed) on September 2, 2026.
- Tenon Medical raised $4.3M (Series A) on August 31, 2026.
- Ark Surgical raised $2.8M (Series A) on August 29, 2026.
- Tenon Medical raised $3M (Post-IPO Equity) on August 28, 2026.
- Endovia Health Sciences, Inc. raised $108K (Funding Round) on August 28, 2026.
Who to call at Reme-D, and when
A new round usually means Reme-D is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Reme-D raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Reme-D, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Reme-D. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Reme-D raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Reme-D raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.